3-(3,4-dihydroxyphenyl)-N-{3-[3-(3,4-dihydroxyphenyl)acryloylamino]propyl}acrylamide

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 肉桂酸及其衍生物
• 英文名称: 3-(3,4-dihydroxyphenyl)-N-{3-[3-(3,4-dihydroxyphenyl)acryloylamino]propyl}acrylamide
• 英文别名: (2E,2'E)-N,N'-(propane-1,3-diyl)bis(3-(3,4-dihydroxyphenyl)acrylamide)；(E)-3-(3,4-dihydroxyphenyl)-N-[3-[[(E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]amino]propyl]prop-2-enamide
• 化学式: C₂₁H₂₂N₂O₆
• 分子量: 398.415
• InChiKey: WRSIYIWYCULGFM-KBXRYBNXSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2
• 重原子数：
  29
• 可旋转键数：
  8
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.14
• 拓扑面积：
  139
• 氢给体数：
  6
• 氢受体数：
  6

反应信息

• 作为产物：
  描述：

  TRANS-咖啡酸 在 吡啶 、 盐酸 、 4-二甲氨基吡啶 、 氯化亚砜 、 三乙胺 、 N,N-二甲基甲酰胺 作用下， 以 二氯甲烷 、 氯仿 、 丙酮 为溶剂， 反应 8.0h， 生成 3-(3,4-dihydroxyphenyl)-N-{3-[3-(3,4-dihydroxyphenyl)acryloylamino]propyl}acrylamide
  参考文献：
  名称：

  Small Molecule Inhibitors of Dynamin I GTPase Activity:  Development of Dimeric Tyrphostins

  摘要：

  Dynamin I is a GTPase enzyme required for endocytosis and is an excellent target for the design of potential endocytosis inhibitors. Screening of a library of tyrphostins, in our laboratory, against the GTPase activity of dynamin I gave rise to a mu M potent lead, 2-cyano-3-(3,4-dihydroxyphenyl)thioacrylamide (1, IC50 70 mu M). Our initial investigations suggested that only the dimeric form of 1 displayed dynamin I GTPase inhibitory activity. Subsequent synthetic iterations were based on dimeric analogues and afforded a number of small molecules, low mu M potent, inhibitors of dynamin I GTPase, in particular, symmetrical analogues with a minimum of two free phenolic -OHs: catechol-acrylamide (9) (IC50 = 5.1 +/- 0.6 mu M), its 3,4,5-trihydroxy congener (10) (IC50 = 1.7 +/- 0.2 mu M), and the corresponding 3-methyl ether (11) (IC50 = 9 3 mu M). Increasing the length of the central alkyl spacer from ethyl to propyl (22-24) afforded essentially identical activity with IC50'S of 1.7 0.2, 1.7 0.2, and 5 +/- 1 mu M, respectively. No decrease in activity was noted until the introduction of a hexyl spacer. Our studies highlight the requirement for two free amido NHs with neither the mono-N-methyl (86) nor the bis-N-methyl (87) analogues inhibiting dynamin I GTPase. A similar effect was noted for the removal of the nitrile moieties. However, modest potency was observed with the corresponding ester analogues of 9-11: ethyl ester (90), propyl ester (91), and butyl ester (92), with IC50'S of 42 3, 38 2, and 61 2 mu M, respectively. Our studies reveal the most potent and promising dynamin I GTPase inhibitor in this series as (22), which is also known as BisT.

  DOI：

  10.1021/jm040208l

文献信息

• Rationally designed divalent caffeic amides inhibit amyloid-β fibrillization, induce fibril dissociation, and ameliorate cytotoxicity
  作者：Ling-Hsien Tu、Ning-Hsuan Tseng、Ya-Ru Tsai、Tien-Wei Lin、Yi-Wei Lo、Jien-Lin Charng、Hua-Ting Hsu、Yu-Sheng Chen、Rong-Jie Chen、Ying-Ta Wu、Yi-Tsu Chan、Chang-Shi Chen、Jim-Min Fang、Yun-Ru Chen

  DOI：10.1016/j.ejmech.2018.08.084

  日期：2018.10

  sheets in Aβ fibrils, showed good potency to inhibit Aβ(1–42) fibrillization. Furthermore, compound 2 effectively dissociated the Aβ(1–42) preformed fibrils. The cytotoxicity induced by Aβ(1–42) aggregates in human neuroblastoma was reduced in the presence of 2, and feeding 2 to Aβ transgenic C. elegans rescued the paralysis phenotype. In addition, the binding and stoichiometry of 2 to Aβ(1–40) were

  阿尔茨海默氏病（AD）的病理特征之一是由淀粉样β（Aβ）原纤维组成的细胞外老年斑。用小分子阻断Aβ自组装或分解Aβ聚集体将是治疗AD的潜在治疗策略。在这项研究中，我们合成了一系列合理设计的二价化合物，并研究了它们对Aβ原纤维化的影响。由两个咖啡酸分子组成的二价酰胺（2），其丙二胺连接基的长度约为5.0Å，与Aβ纤丝中相邻β片的距离接近，显示出良好的抑制Aβ（1-42）原纤维化的能力。 。此外，化合物2有效地解离了Aβ（1-42）预形成的原纤维。在2的存在下，Aβ（1-42）聚集体在人成神经细胞瘤中诱导的细胞毒性降低，向Aβ转基因秀丽隐杆线虫喂食2可挽救麻痹性表型。此外，使用电喷雾电离-旅行波离子迁移率-质谱法证明了2与Aβ（1-40）的结合和化学计量，同时进行了分子动力学模拟以了解Aβ（1-40）-的结构。2复杂。
• Small Molecule Inhibitors of Dynamin I GTPase Activity:  Development of Dimeric Tyrphostins
  作者：Timothy Hill、Luke R. Odell、Jennifer K. Edwards、Mark E. Graham、Andrew B. McGeachie、Jenny Rusak、Annie Quan、Ruben Abagyan、Janet L. Scott、Phillip J. Robinson、Adam McCluskey

  DOI：10.1021/jm040208l

  日期：2005.12.1

  Dynamin I is a GTPase enzyme required for endocytosis and is an excellent target for the design of potential endocytosis inhibitors. Screening of a library of tyrphostins, in our laboratory, against the GTPase activity of dynamin I gave rise to a mu M potent lead, 2-cyano-3-(3,4-dihydroxyphenyl)thioacrylamide (1, IC50 70 mu M). Our initial investigations suggested that only the dimeric form of 1 displayed dynamin I GTPase inhibitory activity. Subsequent synthetic iterations were based on dimeric analogues and afforded a number of small molecules, low mu M potent, inhibitors of dynamin I GTPase, in particular, symmetrical analogues with a minimum of two free phenolic -OHs: catechol-acrylamide (9) (IC50 = 5.1 +/- 0.6 mu M), its 3,4,5-trihydroxy congener (10) (IC50 = 1.7 +/- 0.2 mu M), and the corresponding 3-methyl ether (11) (IC50 = 9 3 mu M). Increasing the length of the central alkyl spacer from ethyl to propyl (22-24) afforded essentially identical activity with IC50'S of 1.7 0.2, 1.7 0.2, and 5 +/- 1 mu M, respectively. No decrease in activity was noted until the introduction of a hexyl spacer. Our studies highlight the requirement for two free amido NHs with neither the mono-N-methyl (86) nor the bis-N-methyl (87) analogues inhibiting dynamin I GTPase. A similar effect was noted for the removal of the nitrile moieties. However, modest potency was observed with the corresponding ester analogues of 9-11: ethyl ester (90), propyl ester (91), and butyl ester (92), with IC50'S of 42 3, 38 2, and 61 2 mu M, respectively. Our studies reveal the most potent and promising dynamin I GTPase inhibitor in this series as (22), which is also known as BisT.